Modern genetic sequencing studies have confirmed that the sperm of older men contain a greater number of de novo germline mutations than the sperm of younger men. Although most of these mutations are neutral or of minimal phenotypic impact, a minority of them present a risk to the health of future children. If demographic trends towards later fatherhood continue, this will likely lead to a more children suffering from genetic disorders. A trend of later fatherhood will accelerate the accumulation of paternal-origin de novo mutations in the gene pool, gradually reducing human fitness in the long term. These risks suggest that paternal age is of ethical importance. Children affected by de novo mutations arising from delayed fatherhood can be said to be harmed, in the sense of ‘impersonal’ harm or ‘non-comparative’ harm. Various strategies are open at societal and individual levels towards reducing deleterious paternal age effects. Options include health education to promote earlier fatherhood, incentives for young sperm donors and state-supported universal sperm banking. The latter approach would likely be of the greatest benefit and could in principle be implemented immediately. More futuristically, human germline genetic modification offers the potential to repair heritable mutational damage.
- Reproductive Medicine
- Interests of Woman/Fetus/Father
- Cryobanking of Sperm, Ova or Embryos
- Genetic Engineering
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Delayed fatherhood
- Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States: population based cohort study
- Paternal age and schizophrenia: a population based cohort study
- Advanced paternal age: How old is too old?
- Neurofibromatosis type 1 families with first-degree relatives harbouring distinct NF1 pathogenic variants. Genetic counselling and familial diagnosis: what should be offered?
- Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study
- Paternal age and the risk of low birth weight and preterm delivery: a Finnish register-based study
- Parental occupational exposures and the risk of childhood sporadic retinoblastoma: a report from the Children’s Oncology Group
- Parental mosaicism detection and preimplantation genetic testing in families with multiple transmissions of de novo mutations
- Case–control analysis of paternal age and trisomic anomalies